- Home
- CTNM
as of 12-12-2025 3:59pm EST
$11.62
$1.46
-11.13%
Stocks Nasdaq
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
Chart Type:
Time Range:
| Founded: | 2009 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 328.1M | IPO Year: | 2024 |
| Target Price: | $20.00 | AVG Volume (30 days): | 254.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.25 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.35 - $15.25 | Next Earning Date: | 10-30-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AI-Powered CTNM Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 3 days ago
AI Recommendation
hold
Model Accuracy: 83.93%
83.93%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Contineum Therapeutics Inc. News
CTNM Breaking Stock News: Dive into CTNM Ticker-Specific Updates for Smart Investing
Business Wire
Contineum Therapeutics Announces Pricing of Upsized $90.0 Million Public Offering
📊
AI Sentiment
Positive
7/10
Business Wire
Contineum Therapeutics Announces Proposed $75.0 Million Public Offering
âž–
AI Sentiment
Neutral
5/10
Compare CTNM vs Leading Stocks
See how CTNM stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "CTNM Contineum Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.